Page 115 - Developing News Today

Obstacles. to 0ldman, bbc news. im a lewis wilsonjones, this is bbc news. turning into a very pleasant day for many parts of the country, more sunshine around. a week by the front is bringing more cloud to scotland and a little rain, a south easterly breeze developing is the area of high pressure tends to move away. that has been keeping a dry but also a bit chilly as it moves away, we will see a south—westerly wind and things will get warmer and also more unsettled. temperatures peaking at 16...

Agenus , a leading immuno-oncology company dedicated to developing innovative treatments for cancer and infectious diseases, today announced a data update on botensilimab in combination with... | May 3, 2023

MIAMI, FL, May 03, 2023 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral... | May 3, 2023

Joby Aviation, Inc. , a company developing all-electric aircraft for commercial passenger service, today announced the pricing of its public offering of 43,985,681 shares of its common stock at a... | May 3, 2023

STAMFORD, Conn., May 02, 2023 -- SpringWorks Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and... | May 2, 2023

BASKING RIDGE, N.J., May 02, 2023 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other... | May 2, 2023

WAYNE, Pa., May 02, 2023 -- Aclaris Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced it... | May 2, 2023

Tay Therapeutics, a University of Dundee spinout, has agreed a licensing deal with US biotech VYNE Therapeutics focused on developing therapies for immuno-inflammatory diseases. Click to read more...

Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today... | May 2, 2023

WALTHAM, Mass., May 02, 2023 -- Morphic Holding, Inc. , a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced... | May 2, 2023